Abstract
Selecting health technologies to finance with public money requires juxtaposing their cost and health gains. Determining the exact values of willingness-to-pay/willingness-to-accept (WTP/WTA) may be difficult and considered unethical. As a solution, both may be treated as fuzzy sets. Then, a crossover-point (CP) of a fuzzy WTP is such a value that a decision maker is just as convinced as unconvinced it is worth paying for a unit of health (analogously for fuzzy WTA). In this fuzzy approach, I motivate why health technologies should be compared using CPs. I introduce three statistical methods of assessing the CP based on random-samples, survey data: using hypothesis testing, Bayesian hierarchical modelling, and frequentist estimation. I use the previously published dataset for Poland and show how the methods may be employed. The results suggest no (significant) difference in CPs for fuzzy WTP and WTA, but more stochastic uncertainty regarding the latter. The estimation methods can be used to assess the fuzzy preferences in other decision problem contexts.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
In applied CEA it is more common to calculate the incremental cost-effectiveness ratios and compare them with WTP, algebraically equivalent to maximizing NB [5].
- 2.
This approach can also be seen (not pursued formally, for brevity) as applying the Orlovsky-score [11]: maximizing the degree to which a given alternative is not dominated by others.
- 3.
The explanation is done for WTP, but refers to WTA mutatis mutandis.
- 4.
Example 1: if the respondent selected option 4 for \(\lambda =100\), option 3 for \(\lambda =125\) and \(\lambda =150\), and option 2 for \(\lambda =175\), then \(C\!R=[112.5; 162.5]\). Example 2: if the respondent selected option 4 for \(\lambda =100\) and immediately switched to option 2 for \(\lambda =125\), then \(C\!R=[106.25; 118.75]\).
- 5.
1 \(\nicefrac {{\text {PLN}}}{{\text {QALY}}}\) added, to avoid \(\ln (0)\).
- 6.
Taking the logs, conveniently, allows using a normal distribution, as the non-log CR are bounded by zero from below.
References
Bellavance, F., Dionne, G., Lebeau, M.: The value of a statistical life: a meta-analysis with a mixed effects regression model. J. Health Econ. 28(2), 444–464 (2009)
Dubois, D., Prade, H.: Fuzzy Sets and Systems: Theory and Applications. Academic Press, New York (1980)
Dykstra, R., Kochar, S., Robertson, T.: Likelihood ratio tests for symmetry against one-sided alternatives. Ann. Inst. Stat. Math. 47(4), 719–730 (1995)
Jakubczyk, M., Kamiński, B.: Fuzzy approach to decision analysis with multiple criteria and uncertainty in health technology assessment. Ann. Oper. Res. 251, 301–324 (2017)
Jakubczyk, M.: Using a fuzzy approach in multi-criteria decision making with multiple alternatives in health care. Multiple Criteria Decis. Making 10, 65–81 (2015)
Jakubiak-Lasocka, J., Jakubczyk, M.: Cost-effectiveness versus cost-utility analyses: what are the motives behind using each and how do their results differ?-a Polish example. Value Health Reg. Issues 4C, 66–74 (2014)
Lee, C., Chertow, G., Zenios, S.: An empiric estimate of the value of life: updating the renal dialysis cost-effectiveness standard. Value Health 12(1), 80–87 (2009)
Lindhjem, H., Navrud, S., Braathen, N., Biausque, V.: Valuing mortality risk reductions from environmental, transport, and health policies: a global meta-analysis of stated preference studies. Risk Anal. 31(9), 1381–1407 (2011)
Matell, M., Jacoby, J.: Is there an optimal number of alternatives for Likert-scale items? effects of testing time and scale properties. J. Appl. Psychol. 56(6), 506–509 (1972)
Neumann, P., Cohen, J., Weinstein, M.: Updating cost-effectiveness-the curious resilience of the $50,000-per-QALY threshold. N. Engl. J. Med. 371(9), 796–797 (2014)
Orlovsky, S.: Decision-making with a fuzzy preference relation. Fuzzy Sets Syst. 1, 155–167 (1978)
Whitehead, A.: Meta-Analysis of Controlled Clinical Trials, 1st edn. Wiley (2002)
Zadeh, L.: Fuzzy sets. Inf. Control 8, 338–353 (1965)
Acknowledgements
The research was financed by the funds obtained from National Science Centre, Poland, granted following the decision number DEC-2015/19/B/HS4/01729.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Switzerland AG
About this paper
Cite this paper
Jakubczyk, M. (2018). Estimating the Crossover Point of a Fuzzy Willingness-to-Pay/Accept for Health to Support Decision Making. In: Kilgour, D., Kunze, H., Makarov, R., Melnik, R., Wang, X. (eds) Recent Advances in Mathematical and Statistical Methods . AMMCS 2017. Springer Proceedings in Mathematics & Statistics, vol 259. Springer, Cham. https://doi.org/10.1007/978-3-319-99719-3_39
Download citation
DOI: https://doi.org/10.1007/978-3-319-99719-3_39
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-99718-6
Online ISBN: 978-3-319-99719-3
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)